Evaluate immunogenicity, safety & reactogenicity of GSK Biologicals' 10-valent pneumococcal conjugate vaccine given as catch-up immunization in children older than 7 mo of age or as 3-dose primary immunization in children before 6 mo of age
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed)
Infections, Streptococcal
Phase 3
An annotated case report form is not available for this study. A blank case report form will be provided.
September 2013